VITA LIFE SCIENCES Aktie

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, VITA LIFE SCIENCES Aktie has already paid €0.088 in dividends. The last payout was in October.

Financials

In the last quarter, VITA LIFE SCIENCES Aktie had revenue of €29.26M and net profit of €3.37M

(EUR)	June 2026	YoY
Revenue	29.26M	-
Gross profit	18.58M	-
Net profit	3.37M	-
EBITDA	4.77M	-

Fundamentals

Metric	Value
Market capitalization	€90.06M
Number of shares	53.9M
52-week high/low	€1.78 - €1.39
Dividend yield	5.43%
Dividends TTM	€0.088
Beta	0.45
P/E ratio	13.60
PEG ratio	0.77
P/B ratio	2.65
P/S ratio	1.53

Company profile

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; pregnancy and breastfeeding; men, women, and children's health; antioxidant; and bones and joints. The company markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.